Why is $GLUE moving today? · SEC 8-K archive

$GLUE SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $GLUE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $GLUE filing catalyst

Why did $GLUE trigger an AI stock catalyst alert?

$GLUE triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Monte Rosa Reports Positive MRT-8102 Phase 1 Data, Cash Balance of $582.6M in Q3 2026. Key points: - Phase 1 GFORCE-1 study met endpoints with Phase 2 trials planned for H1 2027 and Q4 2026 - Cash, cash equivalents and marketable securities stood at $582.6M as of Sept 30, 2026 - Collaboration revenue reached ~$54.3M in Q3 with positive net income recorded

How did $GLUE stock react after the SEC filing?

After the SEC 8-K for $GLUE, observed market reaction: T0 price $10.82. Past moves do not guarantee future results.

Where can I get real-time $GLUE SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $GLUE via Telegram and the VIP Web Terminal from €10/month.

$GLUE – Monte Rosa Reports Positive MRT-8102 Phase 1 Data, Cash Balance of $582.6M in Q3 2026

Monte Rosa Therapeutics, Inc.
· SEC 8-K · All $GLUE

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)
  • Phase 1 GFORCE-1 study met endpoints with Phase 2 trials planned for H1 2027 and Q4 2026
  • Cash, cash equivalents and marketable securities stood at $582.6M as of Sept 30, 2026
  • Collaboration revenue reached ~$54.3M in Q3 with positive net income recorded